Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2008-002136-15Phase 4Terminated
Phase 4, randomised, single-blind trial in postoperative pain comparing Levobupivacaine femoral perineural infusion with Ropivacaine femoral perineural infusion (2 arms). Primary endpoint: Pain intensity at 30 hours post-surgery. Started Jun 2010; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2008-002136-15.